Monday, October 09, 2017 7:09:38 PM
https://vimeo.com/234688381
Written by Jim Mellon (shareholder of CohBar) and Al Chalabi, distils extensive recent research into the science of longevity and also highlights the best opportunities for investors to capitalise on advances that have deep implications for all of our futures.
•Billionaire Jim Mellon Master Investor Show 2017—Investing in Longevity—“The New Money Fountain” Wrote new book on Longevity- Juvenescence: Investing in the age of Longevity
Starts at 28:30
45:00 MetFormin 45:15 Talked to Dr. Nir Barzilai 52:51 List of Longevity companies including CohBar 52:41 Shareholder of CohBar
Presentation
Recent CWBR News
- CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K) • Business Wire • 11/27/2023 11:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 10:21:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 02:01:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 01:05:22 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/25/2023 01:01:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 01:00:42 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/06/2023 08:13:20 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/06/2023 08:11:18 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/04/2023 01:14:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 01:12:48 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/13/2023 04:15:25 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/12/2023 08:47:59 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 09/12/2023 05:44:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:07:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:05:38 PM
- CohBar Reports Second Quarter 2023 Financial Results • GlobeNewswire Inc. • 08/14/2023 08:01:05 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 08/10/2023 09:30:56 PM
- Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) • GlobeNewswire Inc. • 06/05/2023 12:05:22 PM
- Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 05/30/2023 12:05:15 PM
- CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy • GlobeNewswire Inc. • 05/23/2023 11:30:39 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM